Changing Landscape of Research in New Zealand: Insights from HDECs NZACRES 2024
Explore the evolving research landscape in New Zealand through the lens of HDECs NZACRES 2024, as discussed by Elizabeth Bohm, the Principal Adviser on Ethics at the Ministry of Health. The shift in research trends, volume of applications, lifecycle patterns, study types, clinical trials, first-in-human studies, and focus areas are all examined in detail, highlighting the dynamic nature of research practices in the country.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
How research is changing in NZ a view from the HDECs NZACRES 2024 9 August 2024 Elizabeth Bohm, Principal Adviser, Ethics, Manat Hauora | Ministry of Health
Ethics team at the Ministry of Health Was 13 Team Members, currently 8, will be 10 Supporting seven ethics Committees (only 4 are HDECs) Total >60 Committee members ~30 are HDEC members
Understanding what research we are seeing What can we tell from all the applications? Data intern early 2024 Conducted analysis on volumes and what types of research using specialist data programmes Limited to last three years 2024 partial year 11/06/2025 Option to include details in footer 4
Volume of research
How many applications do HDECs see? Applications reviewed 400 350 300 250 200 150 100 50 0 2022 2023 2024 Full Review Expedited Review
Lifecycle of applications All submission types 1400 1200 1000 800 600 400 200 0 Amendment Expedited Review Final Full Review Conclusion or Early Termination Progress Report Protocol Deviation Report/Summary of Results 2022 2023 2024
Study type Study type 400 350 300 250 200 150 100 50 0 2022 2023 2024 Intervention study Observational study
Clinical trials Types of trials 250 200 150 100 50 0 2022 2023 2024 Non-Clinical Clinical
First in human studies First in human trials 250 200 150 100 50 0 2022 2023 2024 Not FIH FIH
Focus of studies Focus of studies 250 200 150 100 50 0 therapeutic benefit prevention lifestyle/behaviour other rehabilitation diagnosis early detection/screening 2022 2023 2024
Studies with AI or machine learning AI/ML 250 200 150 100 50 0 2022 2023 2024
Study population coverage 400 350 300 250 200 150 100 50 0 2022 2023 2024 Domestic International
Sponsorship Sponsorship 400 350 300 250 200 150 100 50 0 2022 2023 2024 Commercial based Investigator-led
Localities 2024 10 98 27 10 3 50 4 34 5 4 2 6 30 2 2 2 2 43 4 24 Map source: Health New Zealand
Areas of research
Scientific areas of research Still in development 11/06/2025 17
11/06/2025 18
Conclusion Constantly reviewing what data we need to collect Assessing what is of value Improvements recommended to how we collect data 11/06/2025 20
